The UK government announced on 15 April 2026 that it is driving forward its target to set up clinical trials within 150 days — a commitment designed to give NHS patients faster access to experimental treatments and position the UK as a global leader in clinical research.
The initiative, announced by the Department of Health and Social Care, aims to streamline regulatory approvals, ethics reviews and site setup so that patients can be enrolled in trials more quickly. For pharmacy professionals — particularly those working in hospital investigational pharmacy and clinical trials units — this has direct workforce and operational implications.
What the 150-day target means
Currently, setting up a clinical trial in the UK — from initial application to the first patient being enrolled — can take significantly longer than 150 days. Delays occur at multiple stages: MHRA regulatory approval, Health Research Authority (HRA) ethics review, NHS trust site setup (including pharmacy readiness), and patient recruitment.
The 150-day target covers the period from a valid application being submitted to the MHRA and HRA through to the first participant being recruited at an NHS site. It requires coordination between regulators, NHS trusts, research networks and pharmacy teams.
Why pharmacy is central to trial delivery
Clinical trials involving investigational medicinal products (IMPs) cannot proceed at an NHS site until the hospital pharmacy is ready to receive, store, dispense and account for the trial medication. This involves:
- IMP procurement and import. Trial sponsors ship investigational medicines to site pharmacies, which must have appropriate storage (including cold chain for biologics and gene therapies) and documentation in place.
- Randomisation and blinding. For blinded trials, pharmacy teams are often responsible for maintaining the blind — dispensing active drug or placebo according to the randomisation schedule without revealing allocation to the clinical team.
- Drug accountability. Every unit of IMP must be tracked: received, dispensed, returned and destroyed. This generates a significant documentation burden.
- Protocol-specific dispensing. Many trial protocols require dose modifications based on patient response, weight-based dosing, or complex preparation (e.g. reconstitution of biologics). Pharmacy teams must be trained on each protocol.
A pharmacy that is not set up — whether due to staffing constraints, storage limitations, or incomplete training — is a bottleneck that delays the entire trial.
Current pharmacy workforce in clinical trials
According to PharmSee's analysis of 200 NHS Jobs listings sampled in April 2026, two roles specifically referenced clinical trials:
- Aseptic / Clinical Trials Pharmacist — salary range £58,379 to £65,723 per annum
- Lead Pharmacist, Cancer Services (Clinical Trials) — salary range £57,528 to £64,750 per annum (12-month fixed term)
These represent the upper end of NHS pharmacy pay scales, reflecting the specialist knowledge required. Both roles sit at NHS Agenda for Change Band 8a or above. PharmSee's broader NHS pharmacy salary data shows that the median advertised pharmacist salary across all NHS postings is approximately £46,000 — meaning clinical trials specialists command a 25–40% premium.
However, the scarcity of these postings in the jobs data — just 2 out of 200 sampled NHS listings (1%) — suggests that clinical trials pharmacy remains a niche specialism. Trusts seeking to accelerate trial setup under the 150-day target may need to invest in expanding this workforce.
Implications for community pharmacy
The 150-day target is primarily a hospital and academic-centre initiative, but community pharmacy is not entirely unaffected:
- Concomitant medication management. Patients enrolled in clinical trials continue to collect their regular prescriptions from community pharmacies. Trial protocols may restrict certain medicines (e.g. specific statins, anticoagulants or supplements). Community pharmacists who are aware that a patient is in a trial can flag potential interactions.
- Post-trial access. Once a trial ends, patients who benefited from the experimental treatment may transition to the newly licensed medicine. Community pharmacies will dispense these — often specialist or high-cost drugs that require specific handling.
- Public awareness. As trials become more common and faster to set up, patient queries about clinical trial participation may increase. Community pharmacists are well placed to signpost patients to the NIHR "Be Part of Research" platform.
What this means for pharmacy careers
For pharmacists considering a career in clinical research, the government's commitment to trial acceleration is a positive signal. It suggests sustained funding, expanding infrastructure and growing demand for pharmacists with Good Clinical Practice (GCP) training and experience in IMP management.
Key career entry points include:
| Role | Typical band | Salary range | Setting |
|---|---|---|---|
| Clinical Trials Pharmacy Technician | Band 5–6 | £29,000–£36,000 | Hospital pharmacy |
| Clinical Trials Pharmacist | Band 7 | £46,000–£53,000 | Hospital pharmacy |
| Lead/Senior Clinical Trials Pharmacist | Band 8a+ | £53,000–£65,000+ | Teaching hospital / research centre |
| Chief Pharmacist (Research) | Band 8c–8d | £70,000–£86,000 | Large trust / specialist centre |
Roles are most commonly found at large teaching hospitals, cancer centres and specialist research units. To explore current pharmacy vacancies — including hospital and NHS roles — visit PharmSee's job board.
Looking ahead
The UK's life sciences sector is a national economic priority, and clinical trials are its backbone. The 150-day target signals that the government expects faster, more efficient trial delivery — and pharmacy teams are one of the critical enablers. Whether this translates into more investigational pharmacy posts, better training pathways, or simply greater pressure on existing teams will depend on how NHS trusts invest in the capability.
For pharmacists and pharmacy technicians interested in this specialism, the growth trajectory appears clear even if the current vacancy volume remains small.
For more information on pharmacy career pathways and salary data, explore PharmSee's salary guides.
Sources: Government drives forward its 150-day clinical trial target — GOV.UK, 15 April 2026; PharmSee NHS Jobs sample data (April 2026); NHS Agenda for Change pay scales 2025/26.